Notice of the making of this Statutory Instrument was published in | ||
“Iris Oifigiúil” of 1st December, 2017. | ||
I, CATHERINE BYRNE, Minister of State at the Department of Health, in exercise of the powers conferred on me by sections 4, 5 (as amended by section 15 of the Misuse of Drugs Act 1984 (No. 18 of 1984) and section 3 of the Misuse of Drugs (Amendment) Act 2016 (No. 9 of 2016)), 18 and 38 of the Misuse of Drugs Act 1977 (No. 12 of 1977), section 5 of the Misuse of Drugs Act 1984 and the Health (Delegation of Ministerial Functions) (No. 4) Order 2017 ( S.I. No. 339 of 2017 ), hereby make the following regulations: | ||
1. (1) These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2017. | ||
(2) The Principal Regulations and these Regulations may be cited together as the Misuse of Drugs Regulations 2017. | ||
2. In these Regulations “Principal Regulations” means the Misuse of Drugs Regulations 2017 ( S.I. No. 173 of 2017 ). | ||
3. Paragraph 1(a) of Schedule 1 to the Principal Regulations is amended— | ||
(a) by inserting “3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700)” after “3,4-Dichloro-N-[[1-(dimethylamino) cyclohexyl]methyl]benzamide (otherwise known as AH-7921)”, | ||
(b) by inserting “Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate)” after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol”, | ||
(c) by inserting “[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (otherwise known as XLR-11)” after “Etryptamine”, and | ||
(d) by inserting “N-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine)” after “1-(4-Methylphenyl)-2-methylaminopropan-1-one”. | ||
| ||
GIVEN under my Hand, | ||
24 November 2017. | ||
CATHERINE BYRNE, | ||
Minister of State at the Department of Health. | ||
EXPLANATORY NOTE | ||
(This note is not part of the Instrument and does not purport to be a legal interpretation.) | ||
The purpose of these Regulations is to amend the Misuse of Drugs Regulations 2017 by inserting into Schedule 1 to those Regulations the following: | ||
3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700); | ||
Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate); | ||
[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (otherwise known as XLR-11); and | ||
N-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine). | ||
These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2017. |